Skip to main content
close
Site Logo
Search site
Search
Home
PDL / PA
Preferred Drug Lists
PA Forms
Prior Authorization Criteria
New Drug Process
Policy for Review of Drug Status
Appeals & Exception to Policy
CDC Guidelines
(External link)
Info Letters / Provider Info
Informational Letters
Latest news
Listserv
Fax Confidentiality Certificate
Billing Information
Billing / Quantity Limits
340B
Frequently Asked Questions
Payer Sheet
Committee / Public Comments
P&T Committee Information
Public Comments
Drugs for Rare Diseases
Rebate Info
Home
PDL / PA
Preferred Drug Lists
PA Forms
Prior Authorization Criteria
New Drug Process
Policy for Review of Drug Status
Appeals & Exception to Policy
CDC Guidelines
(External link)
Info Letters / Provider Info
Informational Letters
Latest news
Listserv
Fax Confidentiality Certificate
Billing Information
Billing / Quantity Limits
340B
Frequently Asked Questions
Payer Sheet
Committee / Public Comments
P&T Committee Information
Public Comments
Drugs for Rare Diseases
Rebate Info
Home
Section
P&T Committee Information
April 16, 2026
Related files
Tentative agenda
Draft PDL - April 16, 2026
Reports
There are no files currently available.
Drug mongraphs
Aqvesme
Blujepa
Ekterly
Exxua
Hyrnuo
Ibtrozi
Inluriyo
Jascayd
Leqembi
Lynkuet
Orlynvah
Palsonify
Rhapsido
Tonmya
Voyxact
Wayrilz
Drug class reviews
There are no files currently available.
Archive
There are no files currently available.
keyboard_arrow_up
back to top
back to top
keyboard_arrow_up
